+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vaccine Adjuvant"

From
From
From
From
From
Bovine Ephemeral Fever Vaccines - Global Strategic Business Report - Product Thumbnail Image

Bovine Ephemeral Fever Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 377 Pages
  • Global
From
Recombinant Vaccines - Global Strategic Business Report - Product Thumbnail Image

Recombinant Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 383 Pages
  • Global
From
Mono Vaccines - Global Strategic Business Report - Product Thumbnail Image

Mono Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 194 Pages
  • Global
From
Vaccine Research - Global Strategic Business Report - Product Thumbnail Image

Vaccine Research - Global Strategic Business Report

  • Report
  • September 2025
  • 172 Pages
  • Global
From
Rabies Vaccine - Global Strategic Business Report - Product Thumbnail Image

Rabies Vaccine - Global Strategic Business Report

  • Report
  • September 2025
  • 467 Pages
  • Global
From
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 468 Pages
  • Global
From
Pertussis Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pertussis Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 285 Pages
  • Global
From
Allergy Vaccines - Global Strategic Business Report - Product Thumbnail Image

Allergy Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 481 Pages
  • Global
From
Subunit Vaccines - Global Strategic Business Report - Product Thumbnail Image

Subunit Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 279 Pages
  • Global
From
Toxoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 282 Pages
  • Global
From
Respiratory Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Respiratory Virus Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 474 Pages
  • Global
From
Multivalent Vaccines - Global Strategic Business Report - Product Thumbnail Image

Multivalent Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 278 Pages
  • Global
From
Mumps Vaccines - Global Strategic Business Report - Product Thumbnail Image

Mumps Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 288 Pages
  • Global
From
Loading Indicator

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus. Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more